AGP Executive Report

FDA & Prostate Cancer: FDA approved a generic Ga-68 PSMA-11 radiodiagnostic (Ga-68 gozetotide) for PSMA PET imaging, adding another PSMA tracer option for suspected metastases and recurrence. Urology Care: In BPH, Kevin Zorn, MD, urged practical adoption of MIST options based on patient fit, with prostate urethral length as a key selection factor beyond prostate volume. OAB Treatment: A reduced onabotulinumtoxinA injection-site protocol for overactive bladder reported near-99% response in a retrospective 90-patient review, with better tolerability. Bladder Cancer Research: Panels highlighted unmet needs in muscle-invasive bladder cancer, including limits of imaging/ctDNA for identifying complete responders and the cautious push toward bladder preservation within trials. Lung Cancer Trial Update: Merck discontinued a phase 3 sacituzumab govitecan plus pembrolizumab study in metastatic PD-L1+ NSCLC after PFS/OS failed to meet statistical goals. CML Advance: 144-week ASC4FIRST data supported asciminib as a frontline chronic-phase CML option with improved molecular responses and tolerability. Stroke Access: Texas awarded $2.5M for new/expanded mobile stroke units to speed care and improve outcomes. Healthcare AI & Consent: A new piece argues AI use needs a distinct consent conversation beyond standard treatment consent, given clinician uncertainty about how tools work. Sleep Apnea Findings: Women starting CPAP for moderate-to-severe OSA reported higher symptom burden than men despite lower AHI. Infectious Disease/Innovation: ASM launched a phage therapy coordination initiative to standardize and accelerate work against drug-resistant infections.

Medicaid & Labor Clash: California’s looming Medicaid cuts are fueling a new fight between SEIU-United Healthcare Workers West and the California Hospital Association, with competing ballot measures targeting executive pay, clinic spending, and union political spending. Animal Health Regulation: Europe’s animal health industry backs a plan to phase out animal testing in chemical safety, but urges the EU to push “new approach methods” globally too. Women’s Heart Health: A viral case highlights how heart disease can be missed in women when symptoms get dismissed as anxiety, underscoring the need for better cardiovascular awareness. Breast Cancer Screening Tech: Commercial AI systems using routine mammograms may flag breast cancer up to six years earlier than radiologists in some cases. GLP-1 Heart Protection: New findings suggest GLP-1 drugs may lower blood clot, ER visit, and death risk in adults with obesity plus autoimmune disease. Cardiology Guideline: AHA/ACC issued the first clinical guideline for cardiovascular-kidney-metabolic (CKM) syndrome, calling for earlier screening and coordinated prevention. Healthcare Access Gaps: A Delhi-NCR study finds many patients feel rushed and turn to Google after visits due to unclear next steps, tests, and referrals. Breast Imaging Expansion: Solis Mammography is opening two new Florida centers with AI-integrated 3D mammography and a “Mammo+Heart” add-on. Aged Care Tech Strain (Australia): A survey says nearly two-thirds of home care providers lack adequate digital systems, forcing manual workarounds. Pharma Deal Watch: GSK’s $10.6B acquisition of Nuvalent keeps oncology M&A in focus.

Oncology Deal: GSK struck a $10.6B agreement to acquire Nuvalent, adding late-stage lung cancer candidates zidesamtinib and neladalkib plus earlier HER2 assets—aimed at expanding GSK’s US oncology push. Healthcare Cybersecurity: A new look at AI-driven healthcare risk highlights rising breach costs and the growing attack surface as hospitals add cloud, connected devices, and AI. Policy & Access: The American Cancer Society updated colorectal screening guidance, reaffirming screening from age 45 to 75 and adding blood-based options for people who won’t complete stool or colonoscopy. PBM Reform: Coverage of the Consolidated Appropriations Act 2026 explains how new CMS enforcement targets PBM contract incentives in Medicare Part D, with implications for independent pharmacies. Home Care Funding: PRN Funding expanded home-care invoice factoring into Ohio, Minnesota, Florida, and Missouri to help agencies manage payroll and staffing amid payment delays. Clinical Practice & AI: A Philips survey finds AI can improve clinician productivity and error detection, but many doctors report AI training gaps. Legal Fight Over Mandates: Ten former hospital employees sued over COVID-19 vaccine mandate denials of religious and medical exemptions. Community Health: The American Red Cross scheduled blood drives across Mississippi Coast amid an earlier-than-expected summer shortage.

Digital Health Innovation: Cimas Healthathon 3.0 launches in Zimbabwe to crowdsource ICT solutions for access, affordability, and fragmented data in healthcare. Rare Disease Access: A look at how “forgotten” medicines can fill major gaps for rare conditions when newer options aren’t available or affordable. Pharma Partnerships & Growth: India’s Piyush Goyal invites global pharma to back India’s innovation push, aiming to double the sector over five years. Cancer Care Equity: A Cardiff woman with relapsed leukemia says she has just six months to live and is raising £500,000 for potentially curative treatment abroad. Insurer Coverage Fight: The AHA files an amicus brief challenging Aetna’s “level of severity” policy, arguing it increases admin burden and threatens coverage transparency. Opioid Treatment Rule: DEA finalizes changes removing a waiver requirement for prescribing medications for opioid use disorder treatment. Public Health & Marketing: STOP urges F1 to end tobacco and nicotine sponsorships amid concerns about youth exposure. Drug Safety & Manufacturing: Haleon plans a ₹2,000 crore India manufacturing facility in Madhya Pradesh to expand supply. Cancer Prevention Vaccine: Oxford and Moderna plan a summer trial of an mRNA vaccine for people with Lynch syndrome to target pre-cancer cells. Clinical Trial Spotlight: Phase 3 data highlight survodutide’s fat-loss and liver-fat reductions in obesity and MASLD. Cardio Screening Potential: Mammography may uncover millions of women with breast arterial calcifications who could benefit from preventive cardiology care.

Transplant Innovation: Emory transplant immunologist Christian P. Larsen, MD, DPhil, FACS, won the ACS Jacobson Innovation Award for decades of work on preventing organ rejection. AI in Surgery: New research highlights how AI is starting to “rewire” neurosurgery via clinical decision support, imaging, and planning—though more real-world validation is still needed. MS Care Updates: At CMSC 2026, experts debated the 2024 McDonald MS diagnostic criteria, the shift toward high-efficacy-first treatment, and how to balance early treatment with later de-escalation. Parkinson’s Real-World Care: Early U.S. real-world data suggest continuous subcutaneous apomorphine infusion can reach an optimized dose without routine antiemetics in many patients. Blood Cancer & Pharma Deals: Incyte agreed to buy Vega Therapeutics for $1.25B to advance a once-monthly von Willebrand disease medicine; Roche also struck a $700M deal with Nurix for a targeted protein-degrading BTK therapy. Cancer Treatment Advances: EU approval landed for subcutaneous isatuximab in multiple myeloma, and new phase 3 prostate cancer data support aglatimagene besadenovec plus valacyclovir with improved disease-free survival. Public Health & Safety: WHO reports Ebola cases in Congo and Uganda have topped 500 as responders face insecurity and misinformation.

Antimicrobial Resistance Oversight: Gaelic Laboratories earned BSI Kitemark Certification for minimised risk of AMR, aligning its antibiotic manufacturing with a new industry standard effective in 2026. Diabetes Care Signals: New ADA data highlight persistent gaps in DKA recognition, with early symptoms often mistaken for common illnesses and leading to costly hospitalizations. Obesity Drug Pipeline: Petrelintide (once-weekly) showed sustained weight loss with tolerability that appears better on nausea than GLP-1s in a phase 2 ZUPREME-1 readout. Workforce & Tech: NHS England is rolling out Microsoft 365 Copilot to 505,000 staff, aiming to cut admin time and free clinicians for patient care. Clinical Trial Access: A survey of metastatic breast cancer patients and physicians finds racial and ethnic minorities face distinct barriers to clinical trial participation, pointing to actionable fixes. Global Health Workforce: Kerala’s CM asked India’s Centre to intervene after Dubai’s Iranian Hospital closure left many Indian healthcare workers facing visa and job uncertainty. Diabetes Tech Updates: Insulet discussed Omnipod 5 improvements aimed at boosting automated mode time and tightening glucose control.

Talc Litigation: A Los Angeles jury ruled Johnson & Johnson was not negligent in selling talc-based baby powder in an ovarian cancer case, a bellwether for tens of thousands of similar lawsuits. Rural Health Funding: Alaska narrowed nearly 1,800 proposals to just over 400 for $272M in Rural Health Transformation Program funding, aimed at offsetting Medicaid work requirement impacts. Next-Gen GLP-1s: Pfizer’s berobenatide is moving into phase 3 with plans for monthly dosing, positioning it as a potentially easier alternative to more frequent injections. Parkinson’s Care Model: A new focus on “connection” highlights support groups and psychosocial engagement as part of comprehensive Parkinson disease treatment. Huntington’s Quality of Life: Real-world survey data suggest deutetrabenazine (and Austedo XR) may improve patient and caregiver-reported quality of life in Huntington disease chorea. Adjuvant RCC Strategy: Discussion of the RAMPART trial weighs durvalumab+tremelimumab benefits against higher toxicity, underscoring the need for better biomarkers. Health Policy & Data Gaps: India’s NFHS-6 fact sheets omit anaemia estimates, with officials pointing to a separate ICMR survey using venous blood. Food Safety Warning: WHO reports unsafe food sickens 860M people and kills 1.5M annually, urging stronger water, sanitation, hygiene, and food safety practices. Healthcare Access & Safety: Maharashtra FDA seized unsterilised gloves falsely labeled sterile, freezing Rs 1.26 crore in stock pending investigation. EMS Staffing Push: Painesville, Ohio seeks FEMA help to add firefighter-paramedics after calls nearly doubled since staffing cuts. Diabetes Tech Framework: ADA-linked guidance promotes structured ketone monitoring action plans to prevent DKA progression.

Diabetes Tech in Primary Care: The ADA’s 2026 Scientific Sessions highlighted the CONNECT randomized trial showing Dexcom G7 CGM use in adults with type 2 diabetes not on insulin cut A1C by 1.6% over 26 weeks—an ADA “highest level A” support signal that could reshape routine care. Obesity Drug Pipeline: At the same meeting, Eli Lilly’s retatrutide posted phase 3 results in both obesity/overweight (TRIUMPH-1) and early type 2 diabetes (TRANSCEND-T2D-1), with major weight loss and A1C improvements reported. Safety Watch on Retatrutide: New safety details shared alongside the data noted arrhythmias and major cardiovascular complications in a small share of retatrutide-treated participants versus none on placebo. Heart Pacing, Noninvasively: Researchers described an ultrasound-based “sonogenetics” pacemaker concept aimed at stabilizing heart activity without implanted devices. Personalized Osteoarthritis Care: A review says osteoarthritis is increasingly diagnosed in people as young as 30 and should be treated as a spectrum of different underlying drivers, not one uniform condition. Disability Support Policy: Kansas’ Money Follows the Person program appears to be facing renewed uncertainty after earlier reductions, raising concerns for people transitioning to independent living. Public Health & Environment: An EPA proposal would roll back coal ash protections, critics say it could worsen contamination and health risks for communities.

Obesity & Diabetes Pipeline: New ADA data back monthly berobenatide dosing, with VESPER-3 showing continued weight loss after switching from weekly to monthly injections, while semaglutide 7.2 mg STEP UP T2D/obesity analyses add renal and inflammation signals beyond diabetes. Drug Safety Oversight: India’s CDSCO made stronger pharmacovigilance compliance mandatory for pharma firms to tighten adverse drug reaction monitoring and reporting. Healthcare Access & Pricing: TrumpRx.gov expands with 160 more discounted drugs, pushing the total above 800 and aiming to bypass insurance middlemen for cash-paying patients. Clinical Innovation: A “living” adhesive bandage uses engineered cells in a hydrogel to drive faster wound healing, and an ISSCR/Harvard clinician course targets growing stem-cell therapy use in Parkinson’s care. Neurology Trials: SKY-0515 interim Huntington results report sustained mutant huntingtin reductions, while exploratory analyses suggest earlier pimavanserin initiation may improve Parkinson’s psychosis symptom trajectories. Public Health Watch: A review links any alcohol intake to higher cancer risk, and a study finds hallucinogen use may slightly raise valvular heart disease risk—both fueling calls for safer monitoring as use grows. Policy & Systems: CMS updated complaint/enforcement reporting on health insurance reforms, and the House Appropriations bill outlines FY 2027 funding priorities for rural health, primary care, workforce, and behavioral health.

China–Pakistan Health Tech: China and Pakistan unveiled a Zhejiang-Pakistan joint lab for herbal medicine R&D, aiming to deepen traditional medicine cooperation. Regulatory Milestone: Pakistan secured observer status at ICH, a step meant to modernize DRAP and align standards with global regulators. HIV Prevention Breakthrough: South Africa officially launched the twice-yearly injectable HIV prevention rollout of lenacapavir, backed by major Global Fund and CIFF funding. Cancer & Drug Policy: A U.S. Supreme Court ruling backed Hikma in a “skinny label” patent dispute over generic Vascepa, while a Los Angeles jury sided with J&J in a talc ovarian cancer case. Public Health Watch: India reported suspected Ebola in Jaipur with tests pending, and Argentina expanded its hantavirus outbreak investigation after a cruise-linked cluster. Care Access & Systems: Santa Clara County leaders urged state funding to protect public hospitals from looming federal cuts. Diabetes Prevention Tech: An EHR-based machine learning model flagged adults at high type 2 diabetes risk up to 10 years ahead.

FDA & Biologics Access: The FDA approved ranibizumab-hkdz as an interchangeable biosimilar to Lucentis, available in both vials and prefilled syringes—an uptake boost for high-volume retina practices. Oncology Practice Changes: ASCO 2026 data added momentum for multiple cancers: camrelizumab plus rivoceranib with TACE improved progression-free survival in unresectable HCC; tarlatamab won EU authorization for extensive-stage small cell lung cancer; and SENOMAC showed axillary lymph node dissection can be omitted in select breast cancer without worse long-term survival, with fewer severe arm-function problems. Infectious Disease Preparedness: Infectious disease experts say hantavirus pandemic fears are low, but stress PPE and local/state readiness for rare outbreaks. Women’s Health Policy: The FDA has started a new safety review of mifepristone, focusing on telehealth and mail-order access amid abortion-pill restrictions debate. Digital Care & Pain: A new app connects acute pain patients to clinicians and routes treatment options, prescriptions, and prior authorization. Global Health: South Africa rolled out twice-yearly lenacapavir for HIV prevention, aiming to reach millions over the next three years.

Heart Care Breakthrough: Narayana Health used artificial heart pumps (VADs) to keep three critically ill teenagers alive until donor transplants, with all three now home after successful surgery. Community Health & Access: Brevard County’s Polly Helm is rallying support for a second heart transplant as her transplanted heart fails. MS Specialty Pharmacy: World MS Day coverage highlights how integrated specialty pharmacy support can improve diagnosis navigation, adherence, and long-term disease management. Neurology Drug Update: FENhance MS trials report strong efficacy and favorable safety for fenebrutinib, aiming to target both inflammation and progression. Research Funding Alarm: Radiologists warn a new federal grant rule could politicize research funding and add heavy compliance burdens. Public Health & Equity: US asthma care shows persistent racial and ethnic gaps in long-acting inhaler use, even as overall use declines. Maternal-Infant Screening: A German study finds umbilical cord blood glucose doesn’t reliably predict transitional neonatal hypoglycemia. Cancer Supply Risk: India faces a cisplatin/carboplatin shortage that could delay curative cancer treatment. Healthcare Tech & Safety: A new report flags rising healthcare data breaches driven by hacking, underscoring cybersecurity urgency. NHS Capacity Moves: Hospital@Home expands hospital-level care into patients’ homes to ease pressure and improve outcomes.

FDA Watch: Baxdrostat (Baxfendy) gets FDA approval as a first-in-class aldosterone synthase inhibitor for adults with uncontrolled hypertension despite other meds, adding a new upstream option for primary care. Regulatory Roundup: FDA also approved/expanded multiple primary-care relevant items, including Afrezza for children and adolescents with diabetes and a ready-to-use romidepsin generic for cutaneous T-cell lymphoma. Cancer Screening: The American Cancer Society updated colorectal screening guidance to include a blood test plus newer stool-based options, aiming to boost uptake among adults still unscreened. Transplant Access: HCV+ donor pancreases can shorten wait times for HCV- recipients without worse graft or survival outcomes, supporting broader use of these organs. Dermatology + Metabolism: A trial found ixekizumab plus tirzepatide helped more patients with psoriasis and obesity reach skin clearance and meaningful weight loss than ixekizumab alone. Oncology at ASCO: Real-world data and new tools highlighted shifting practice patterns, including an AI approach to scale prostate cancer guideline interpretation. Pharma Business & Policy: Lilly escalated its 340B claims-data enforcement, while coverage also spotlighted PBM rebate and revenue-cycle pitfalls. Tech in Drug Discovery: Alnylam and Inceptive launched a multi-year AI collaboration to speed RNA interference therapeutic discovery. Pet Safety: Veterinarians warn GLP-1 drugs are increasingly dangerous to pets if swallowed or chewed, urging secure storage.

Healthcare Finance & Growth: RadNet is seeking a $200M term loan to fund imaging expansion and acquisitions, adding to its 440 outpatient centers across 11 states. Medicare Policy: Penn’s Amol Navathe was named chair of the congressional Medicare Payment Advisory Commission, bringing a clinician-researcher view to Medicare payment debates. Physician Workforce & Pay: With a projected physician shortfall, practices are moving toward hybrid compensation models that blend base pay with productivity and quality incentives. Access & Operations: A new survey finds staffing shortages are increasingly limiting patient access, while health systems are turning to hybrid human-and-AI workflows to keep up. Hospital Pharmacy: A Bluesight survey flags drug shortages, staffing strain, and 340B pricing pressures as top hospital pharmacy concerns. Oncology Pipeline: ASCO updates include early signals for a dual-target ADC in mCRPC and multiple new trial readouts across cancers. Infectious Disease & Prevention: NYC malaria cases tied to migration show rising Plasmodium vivax proportions, and a claims-based study links pediatric flu vaccination to fewer influenza diagnoses. Digital Health & AI: Mayo Clinic and Microsoft are co-developing a “safe and trusted” healthcare AI model, and Elsevier is buying Wellsheet to better connect EHR data with clinical decision support. Drug Pricing & Policy: Public Citizen urges action on pharmaceutical patent abuse and monopoly-driven pricing tactics as lawmakers weigh reforms.

Community Eye Care Expansion: Primary Eyecare Services hit a major milestone, delivering more than one million patient assessments in 2025/26 across 800+ neighbourhoods in partnership with Integrated Care Boards, aiming to ease pressure on the wider NHS. Ebola Preparedness: Nepal’s Ministry of Health placed high alert for Ebola prevention and control, boosting surveillance at Tribhuvan International Airport and border areas and preparing testing and infection-control steps for health workers. Medicaid Work Requirements Pushback: The AAMC criticized CMS’s interim final rule on Medicaid work requirements, saying it narrows state flexibility on self-attestation and frailty exemptions, risking coverage losses and more uncompensated care. Urology Innovation: The FDA approved Coloplast’s Titan Prime inflatable penile prosthesis for severe erectile dysfunction, touting durability and improved pump activation. AI in Healthcare Operations: Healthcare Brew’s AI 411 roundup highlights new AI training and adoption efforts across health systems and life sciences, including CVS’s AI Learning Academy and other funding-backed tools. Pharma Supply Chain & Quality: SGS launched GMP-compliant NMR testing in China to strengthen identity, purity, and quality checks for drug development and manufacturing.

Medicaid Policy Shock: Advocates say the Trump administration’s Medicaid work requirements are getting tougher than expected, with “medical frailty” exemptions harder to qualify for—raising the risk of large, harmful coverage losses for sick and disabled people. Drug Pricing Fight: Eli Lilly says it will deny 340B discounts to providers that miss documentation requirements next week, while the AHA urges federal action as hospitals warn of added administrative burden and patient harm. Hospital Cost Blueprint: The AHA released a blueprint aimed at lowering healthcare costs and expanding access, targeting admin waste, and drug/device pricing and delivery reforms. AI Cybersecurity Push: A White House executive order directs agencies to harden cybersecurity for AI systems, create an AI cybersecurity clearinghouse, and prioritize enforcement against illegal AI-enabled hacking. Insurance Antitrust Lawsuit: Arizona AG Kris Mayes sued major insurers over alleged price-fixing of provider reimbursements using shared data and an algorithm via MultiPlan. CAR-T Access Logistics: Cencora and Kite agreed to expand US distribution for CAR T therapies, aiming to cut operational friction for community sites. Stroke Trial Update: JAMA reports IV tenecteplase before EVT didn’t improve outcomes for late-window proximal MCA occlusion. Acne OTC Expansion: FDA approved Differin Epiduo Acne Gel for over-the-counter use for ages 12+.